Breast Cancer Clinical Trial
The Cancer of the Pancreas Screening-5 CAPS5)Study
Summary
Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at their site.
Full Description
The Sub Investigator at each site will be responsible for internal monitoring at their site. The site sub Investigator and study team will report any serious adverse events to Principal Investigator and annually report adverse events.
Eligibility Criteria
Inclusion Criteria:
Hereditary Pancreatitis or
Peutz-Jeghers Syndrome or
Strong family history of pancreas cancer on one side of the family tree or
Confirmed germline mutation carrier (BRCA2, FAMMM, PALB2, BRCA1, HNPCC, PRSS1/2, or CTRC
Endoscopic evaluation of pancreas scheduled
Exclusion Criteria:
Medical comorbidities or coagulopathy that contraindicate endoscopy
Prior surgery that prevent optimal endoscopic ultrasound such as partial or complete gastrectomy with Bilroth or Roux-en-Y anastomosis
Stricture or obstruction in the upper GI tract that does not allow passage of the echoendoscope
Poor performance status
Inability to provide informed consent
Pregnancy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 8 Locations for this study
New Haven Connecticut, 06520, United States More Info
Principal Investigator
Baltimore Maryland, 21287, United States More Info
Principal Investigator
Sub-Investigator
Boston Massachusetts, 02215, United States More Info
Principal Investigator
Ann Arbor Michigan, 48109, United States More Info
Sub-Investigator
New York New York, 10032, United States More Info
Principal Investigator
Cleveland Ohio, 44106, United States More Info
Sub-Investigator
Philadelphia Pennsylvania, 19104, United States More Info
Sub-Investigator
Pittsburgh Pennsylvania, 15213, United States More Info
Principal Investigator
How clear is this clinincal trial information?